RS BioTherapeutics, Inc. — Form C-AR (Regulation Crowdfunding)
RS BioTherapeutics, Inc. of Cumberland, MD filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2025-05-02.
Offering
- Filed: 2025-05-02
- Form: C-AR
- Accession: 0001665160-25-000955
Issuer
- CIK: 0001932193
- Website: http://rsbiotherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-02-08
- Address: 157 Baltimore St. Suite 140, Cumberland, MD, 21502
- Employees: 5
Financials (as filed)
- Total assets (most recent): $41K
- Cash (most recent): $14K
- Short-term debt: $590K
- Long-term debt: $189K
People (6)
| Name | Role | Location |
|---|
| Curtis Rhine | CFO | Cumberland, MD |
| Dustin Freas | Board Director | Hunt Valley, MD |
| Dean Hart | CEO | Cumberland, MD |
| Dean Hart | Chief Executive Officer | Cumberland, MD |
| Justin Molignoni | Chairman of the Board | Cumberland, MD |
| Curtis R Rhine | Chief Financial Officer | Cumberland, MD |
Reg CF filing history (4)
More